Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 4 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Zai Lab Ltd as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- +3 vs. Q3 2023
- Shares held
- 41.1M
- +1.75M (+4.4%) vs. Q3 2023
- Total value
- $1.12B
- +$169.0M (+17.7%) vs. Q3 2023
- New holders
- 22
- 33 more added
- Sold out
- 19
- 45 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZLAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $819.0M |
| Q1 2026 | 99 | $530.9M |
| Q4 2025 | 126 | $510.5M |
| Q3 2025 | 138 | $1.19B |
| Q2 2025 | 156 | $1.49B |
| Q1 2025 | 160 | $1.97B |
| Q4 2024 | 131 | $1.48B |
| Q3 2024 | 104 | $1.09B |
| Q2 2024 | 105 | $702.4M |
| Q1 2024 | 117 | $659.7M |
| Q4 2023 | 124 | $1.12B |
| Q3 2023 | 122 | $954.6M |
| Q2 2023 | 138 | $1.19B |
| Q1 2023 | 161 | $1.76B |
| Q4 2022 | 167 | $1.78B |
| Q3 2022 | 171 | $2.03B |
| Q2 2022 | 166 | $2.09B |
| Q1 2022 | 176 | $2.71B |
| Q4 2021 | 207 | $4.06B |
| Q3 2021 | 228 | $6.76B |
| Q2 2021 | 234 | $11.0B |
| Q1 2021 | 222 | $7.24B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Zai Lab Ltd; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 325,013 | $8.88M | 0.06% | +325,013 | New |
| FIL Ltd | 394,469 | $10.8M | 0.01% | 00.0% | Unchanged |
| Vivo Capital, LLC | 411,677 | $11.3M | 0.92% | −42,929−9.4% | Reduced |
| Brilliance Asset Management Ltd | 435,926 | $11.9M | 2.58% | +278,841+177.5% | Added |
| M&G Investment Management Ltd | 457,727 | $12.4M | 0.07% | −9,264−2.0% | Reduced |
| BlackRock Inc. | 560,649 | $15.3M | 0.00% | +31,182+5.9% | Added |
| State Street Corp | 659,805 | $18.0M | 0.00% | +12,844+2.0% | Added |
| Legal & General Group Plc | 676,221 | $18.5M | 0.01% | −18,404−2.6% | Reduced |
| Allianz Asset Management GmbH | 679,524 | $18.6M | 0.03% | +140,461+26.1% | Added |
| Genesis Investment Management, LLP | 692,663 | $18.9M | 3.71% | −339,503−32.9% | Reduced |
| Capital International Investors | 806,453 | $22.0M | 0.00% | −38,900−4.6% | Reduced |
| Clearbridge Investments, LLC | 823,400 | $22.5M | 0.02% | +512+0.1% | Added |
| Paradigm Biocapital Advisors LP | 1,091,779 | $29.8M | 1.40% | −50,604−4.4% | Reduced |
| Rock Springs Capital Management LP | 1,137,023 | $31.1M | 0.77% | −100,000−8.1% | Reduced |
| FMR LLC | 1,236,927 | $33.8M | 0.00% | −31,275−2.5% | Reduced |
| Bamco Inc | 1,490,874 | $40.7M | 0.11% | −88,475−5.6% | Reduced |
| Segantii Capital Management Ltd | 1,687,569 | $46.5M | 2.72% | −101,430−5.7% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,869,283 | $51.1M | 0.19% | −621,720−25.0% | Reduced |
| Invesco Ltd. | 1,893,529 | $51.8M | 0.01% | −1,315,774−41.0% | Reduced |
| Woodline Partners LP | 2,018,527 | $55.2M | 0.60% | +1,217,133+151.9% | Added |
| Price T Rowe Associates Inc | 2,704,455 | $73.9M | 0.01% | −12,139−0.4% | Reduced |
| Janus Henderson Group PLC | 4,040,282 | $110.4M | 0.07% | −202,944−4.8% | Reduced |
| Capital World Investors | 5,218,843 | $142.6M | 0.03% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,336,457 | $145.8M | 0.03% | +3,413,829+177.6% | Added |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −144,838−100.0% | Sold out |
| XY Capital Ltd | 0 | $0 | 0.00% | −139,743−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −118,792−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −100,967−100.0% | Sold out |
| Atika Capital Management LLC | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Long Corridor Asset Management Ltd | 0 | $0 | 0.00% | −31,000−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −19,777−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −19,030−100.0% | Sold out |
| Hongkou Capital LP | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −13,691−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −10,614−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −9,702−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −9,667−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −2,344−100.0% | Sold out |
| Van Eck Associates Corp | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −141−100.0% | Sold out |
| Sands Capital Management, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |